WILMETTE, Ill., March 30, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on...
Exebacase Phase 3 DISRUPT study enrollment ongoing in patients with Staph aureus bloodstream infections; results from interim futility analysis anticipated...
Press release Ecully, 29 March 2021 – 6 p.m. Continued international development Workshop in Thailand dedicated to Spineway implants and...
Wambach joins a growing team assembled to increase awareness regarding the unmet medical need for a treatment for brain injuries...
COPENHAGEN, Denmark, March 30, 2021 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative...
Silence Therapeutics Reports Full-year 2020 ResultsAdvancing clinical programmes; On-track for three phase 1 data readouts in 2021 30 March 2021...
Phase 1a data update from clinical ACTengine® programs demonstrated first anti-tumor activity at early phases of dose escalation in heavily...
MIAMI, March 30, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing...
SAN FRANCISCO, March 30, 2021 (GLOBE NEWSWIRE) -- Augmedix, Inc. (“Augmedix”), a leading provider of remote medical documentation and live...
Tests designed to detect active COVID-19 infection with a simple, easy-to-use workflowBETHLEHEM, Pa., March 30, 2021 (GLOBE NEWSWIRE) -- OraSure...
TORONTO, March 30, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (CSE: SILO), a wellness company in the psychedelics and functional...
TEL AVIV, Israel, March 30, 2021 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced that it will host a...
Company shares preliminary results from Phase 1/2 clinical trial with patients who have complete or near-complete blindness NEW YORK, March...
Clinical and pathological findings from clinical trial of the Bria-IMT™ regimen alone and in combination with immune checkpoint inhibitors in...
BNT162b2 vaccine approved or authorized for emergency or temporary use in over 65 countries and regions after successful global Phase 3...
Oakville, Ontario--(Newsfile Corp. - March 30, 2021) - Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) (FSE: CT9) ("Cardiol" or the...
MINNEAPOLIS--(BUSINESS WIRE)--#ourpassionyourlife--Smiths Medical, a leading medical device manufacturer, announces the release of the ECRI evaluation report for CADD®-Solis v4 with...
CHICAGO--(BUSINESS WIRE)--Driven by pandemic realities and clinical demand for portable and intelligent point-of-care ultrasound (POCUS), GE Healthcare today unveiled Venue...
Results demonstrate company’s commitment to client service, outpacing competitors NEW YORK--(BUSINESS WIRE)--#PBM--Capital Rx, the fastest-growing pharmacy benefit manager in the...
CHICAGO--(BUSINESS WIRE)--#AR--Augmedics, a pioneer in augmented reality surgical image guidance, announced today that it has raised $36 million in an...